S100A16 and Nephropathy: We reported that S100A16 activated HRD1, an E3 ubiquitin ligase, that degraded GSK3β and CK1α, the major members of the β-catenin degradation complex, then allowed β-catenin to release and translocate to the nucleus, leading to severe kidney damage.